OTCDD

[sarals]

Vector Medical Technologies

http://biz.yahoo.com/prnews/010405/flth004.html

Vector Medical Technologies, Inc. is a development stage biopharmaceutical technology company developing Met-enkephalin for the treatment of AIDS, as well as the research and development of a non-invasive transdermal delivery system for a wide variety of high-density molecular weight drugs such as Insulin, Collagen, Elastin and other large molecular weight compounds. Such technology, if developed, approved by the appropriate governmental agencies and then commercialized, could enable the non-invasive delivery of drugs currently administered by injection. Vector, through its collaboration and business relationships with various physicians, researchers, medical institutions and others, plans to develop, commercialize and market a variety of products for the transdermal delivery of macromolecule drugs, including Met-enkephalin